Cystic Fibrosis, Pulmonary
Rare Diseases
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Arrowhead PharmaceuticalsARO-ENaC
Clinical Trials (1)
Total enrollment: 43 patients across 1 trials
Study of ARO-ENaC in Healthy Volunteers and in Patients With Cystic Fibrosis
Start: Jul 2020Est. completion: May 202243 patients
Phase 1/2Terminated
Related Jobs in Rare Diseases
Manager, Gene Therapy Operations (GTO)
Genetix Biotherapeutics
10h ago
From $130K/yr
Manager, Gene Therapy Operations (GTO)
Genetix Biotherapeutics
Somerville, Massachusetts, United States
10h ago
Manager, Expert Scientific Writer
Bristol Myers Squibb
Otemachi-JP
23h ago
Ultra-Rare Disease Territory Account Specialist – Denver, CO
Novartis
Field Sales (USA)
23h ago
$132K - $246K/yr
Ultra-Rare Disease Territory Account Specialist – Phoenix, AZ
Novartis
Field Sales (USA)
23h ago
$132K - $246K/yr
Medical Engagement Manager – Diamyd Medical
Bonesupport
Stockholm, Sweden
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space